Journal article
G. Li Petri, S. Di Martino, M. De Rosa
Journal of Medicinal Chemistry, 2022
Journal of Medicinal Chemistry, 2022
Semantic Scholar
DOI
PubMed
Cite
Cite
APA
Click to copy
Petri, G. L., Martino, S. D., & Rosa, M. D. (2022). Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors. Journal of Medicinal Chemistry.
Chicago/Turabian
Click to copy
Petri, G. Li, S. Di Martino, and M. De Rosa. “Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.” Journal of Medicinal Chemistry (2022).
MLA
Click to copy
Petri, G. Li, et al. “Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.” Journal of Medicinal Chemistry, 2022.
BibTeX Click to copy
@article{g2022a,
title = {Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.},
year = {2022},
journal = {Journal of Medicinal Chemistry},
author = {Petri, G. Li and Martino, S. Di and Rosa, M. De}
}
Abstract
The use of peptides as therapeutics has often been associated with several drawbacks such as poor absorption, low stability to proteolytic digestion, and fast clearance. Peptidomimetics are developed by modifications of native peptides with the aim of obtaining molecules that are more suitable for clinical development and, for this reason, are widely used as tools in medicinal chemistry programs. The effort to disclose innovative peptidomimetic therapies is recurrent and constantly evolving as demonstrated by the new lead compounds in clinical trials. Synthetic strategies for the development of peptidomimetics have also been implemented with time. This perspective highlights some of the most recent efforts for the design and synthesis of peptidomimetic agents together with their biological evaluation toward a panel of targets.